Evidence map›Paper›PMID 32483479›Full record

ArticleBasic and clinical neuroscience

Evaluating the Antidepressant Effect of Verbena officinalis L. (Vervain) Aqueous Extract in Adult Rats.

Amina Bekara, Ali Amazouz, Tahir Benyamina Douma

Open access · diamondAbstract read
In one paragraph

Article in Basic and clinical neuroscience. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Plants (Basel, Switzerland) · 2025
    Article
  2. Article
  3. Review
  4. Metabolic Profiling by GC-MS,Molecules (Basel, Switzerland) · 2022
    Article
  5. In Vitro Antimelanoma Properties ofMolecules (Basel, Switzerland) · 2022
    Article
  6. Hydroalcoholic Extract ofIranian journal of pharmaceutical research : IJPR
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Amina BekaraLaboratory of Natural BioResources, University of Hassiba Benbouali, Chlef, Algeria.ORCID 0000-0002-6450-2996
Ali AmazouzLaboratory of Natural BioResources, University of Hassiba Benbouali, Chlef, Algeria.ORCID 0000-0001-9539-7140
Tahir Benyamina DoumaLaboratory of Natural BioResources, University of Hassiba Benbouali, Chlef, Algeria.ORCID 0000-0002-4661-0299
Hassiba Benbouali University of Chlef · DZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe present study aimed to investigate the antidepressant effect of Verbena (V.) officinalis L. aqueous extract in adult female rats.

methodsThe present study evaluated the antidepressant effect of V. officinalis L. aqueous (V AE) extract in female rats using the Forced-Swimming Test (FST), Light-Dark Box (LDB) test, and Open Field Test (OFT). The level of glycemia and histological analysis were also studied. The VAE [200 mg/kg Parenterally (PO)] was administered orally for 7 successive days in the separate groups of rats.

resultsThe oral administration of V. officinalis L. aqueous extract significantly decreased (P< 0.01) the immobility time in the FST, increased the time spent in the light area (LDB), and the number of entry into the central squares (OFT). Thus, the extract at a dose of 200 mg/kg significantly decreased the glycemia level (P<0.05) and suggested no harmful effect on brain histology.

conclusionVerbena officinalis L. aqueous extract at a dose of 200 mg/kg could have an anti-depressant effect in adult rats.

Indexed as

Aqueous extractDepressionNeurobehavioral testsVerbena officinalis L

Identifiers

PMID32483479
PMCPMC7253814
OpenAlexW3023257781

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.